null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-002123-15-FR

Enrollment

Unknown

Registered

2012-09-05

Start date

2014-06-11

Completion date

Unknown

Last updated

2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative pain MedDRA version: 15.0 Level: LLT Classification code 10036286 Term: Post-operative pain System Organ Class: 10022117 - Injury, poisoning and procedural complications

Interventions

Trade Name: CHIROCAÏNE 2,5 mg/ml Product Name: CHIROCAÏNE 2,5 mg/ml Pharmaceutical Form: Injection CAS Number: 27262-48-2 Other descriptive name: LEVOBUPIVACAINE HYDROCHLORIDE Concentration unit: mg/m

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactPatrick Lacarin

CHU de clermont-Ferrand

placarin@chu-clermontferrand.fr003373751195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026